News
The best steroids for women are typically mild compounds like Anavar (Oxandrolone) and Winstrol (Stanozolol). These oral ...
Mr. Yevgeniy Meshcherekov is a seasoned financial executive and Chartered Professional Accountant, bringing over 20 years of post-designation experience across public practice, private enterprise, and ...
SAN JOSE, Calif., April 29, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...
GENFIT’s 2024 Universal Registration Document includes, in particular : The Statutory Auditors’ reports on the annual and consolidated financial statements and related-party agreements, The table ...
This exclusive private label distribution agreement with Smith+Nephew is a significant development for Nuo ,” commented David Jorden, Nuo’s Chief Executive and Financial Officer. “ We could not ...
Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable ...
DUBLIN and BRIDGEWATER, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN) today announced it has regained compliance with the Nasdaq Stock Market (“Nasdaq”) continued ...
About CooperCompanies CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, ...
First-in-class examples of direct SHOC2 binders and modulators of SMP complex assembly identified with potential to block oncogenic RAS/MAPK pathway signaling SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE ...
LX-101, a Novel, Clinical Stage, Payload-Bearing Targeted Therapy Directed to the Insulin-Like Growth Factor Receptor (IGF-1R), Demonstrates Potent Anti-Tumor Activity in Ewing Sarcoma Animal Models ...
The current publication, “ Four-year follow-up from a prospective, multicenter study of percutaneous 60-day peripheral nerve stimulation for chronic low back pain ” appears in Pain and Therapy and the ...
The Phase 3 ABTECT trials (Studies 105 and 106) evaluating obefazimod in patients with moderately to severely active ulcerative colitis successfully enrolled 1,275 participants, exceeding the target ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results